Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash from Investing Activities (2016 - 2025)

Mesa Laboratories' Cash from Investing Activities history spans 16 years, with the latest figure at -$732000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 9.96% year-over-year to -$732000.0; the TTM value through Dec 2025 reached -$3.8 million, down 25.24%, while the annual FY2025 figure was -$4.5 million, 94.47% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$732000.0 at Mesa Laboratories, up from -$1.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $426000.0 in Q1 2024 and bottomed at -$302.9 million in Q4 2021.
  • The 5-year median for Cash from Investing Activities is -$972500.0 (2021), against an average of -$20.2 million.
  • The largest annual shift saw Cash from Investing Activities tumbled 122512.15% in 2021 before it surged 141.52% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$302.9 million in 2021, then skyrocketed by 97.82% to -$6.6 million in 2022, then plummeted by 1123.92% to -$80.8 million in 2023, then skyrocketed by 98.99% to -$813000.0 in 2024, then increased by 9.96% to -$732000.0 in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Cash from Investing Activities are -$732000.0 (Q4 2025), -$1.1 million (Q3 2025), and -$1.0 million (Q2 2025).